Synthesis, Characterization, Theoretical Studies and in Vitro Embriyotoxic, Genotoxic and Anticancer Effects of Novel Phenyl(1,4,6-Triphenyl-2-Thioxo-1,2,3,4-Tetrahydropyrimidin-5-yl)Methanone

References

• V. Sharma, N. Chitranshi, and A. K. Agarwal, “Significance and Biological Importance of Pyrimidine in the Microbial World,” International Journal of Medicinal Chemistry 2014 (2014): 202784. doi:10.1155/2014/202784
   PubMedGoogle Scholar
• M. G. Valverde, and T. Torroba, “Sulfur-Nitrogen Heterocycles,” Molecules 10, no. 2 (2005): 318–320. doi:10.3390/10020318
   Web of Science ®Google Scholar
• R. Dua, S. Shrivastava, S. K. Sonwane, and S. K. Srivastava, “Pharmacological Significance of Synthetic Heterocycles Scaffold: A Review,” Advances in Biological Regulation 5 (2011): 120–144.
   Google Scholar
• T. Sasada, F. Kobayashi, N. Sakai, and T. Konakahara, “An Unprecedented Approach to 4, 5-Disubstituted Pyrimidine Derivatives by a ZnCl2-Catalyzed Three-Component Coupling Reaction,” Organic Letters 11, no. 10 (2009): 2161–2164. doi:10.1021/ol900382j
   PubMed Web of Science ®Google Scholar
• S. Yuan, B. Yu, and H. M. Liu, “New Drug Approvals for 2019: Synthesis and Clinical Applications,” European Journal of Medicinal Chemistry 205 (2020): 112667. doi:10.1016/j.ejmech.2020.112667
   PubMed Web of Science ®Google Scholar
• Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Christopher J. Helal, Jacob C. DeForest, Peter D. Morse, Subham Mahapatra, Christopher J. O'Donnell, et al. “Synthetic Approaches to New Drugs Approved during 2018,” Journal of Medicinal Chemistry 63, no. 19 (2020): 10652–10704. doi:10.1021/acs.jmedchem.0c00345
   PubMed Web of Science ®Google Scholar
• J. Akhtar, A. A. Khan, Z. Ali, R. Haider, and M. S. Yar, “Structure-Activity Relationship (SAR) Study and Design Strategies of Nitrogen-Containing Heterocyclic Moieties for Their Anticancer Activities,” European Journal of Medicinal Chemistry 125 (2017): 143–189. doi:10.1016/j.ejmech.2016.09.023
   PubMed Web of Science ®Google Scholar
• J. Jampilek, “Heterocycles in Medicinal Chemistry,” Molecules (Basel, Switzerland) 24, no. 21 (2019): 3839. doi:10.3390/molecules24213839
   PubMed Web of Science ®Google Scholar
• F. Shi, J. Ding, S. Zhang, W. J. Hao, C. Cheng, and S. Tu, “Substrate-Controlled Chemoselective Synthesis and Potent Cytotoxic Activity of Novel 5,6,7-Triarylpyrido[2,3-d]Pyrimidin-4-One Derivatives,” Bioorganic & Medicinal Chemistry Letters 21, no. 5 (2011): 1554–1558. doi:10.1016/j.bmcl.2010.09.114
   PubMed Web of Science ®Google Scholar
• S. Kumar, and B. Narasimhan, “Therapeutic Potential of Heterocyclic Pyrimidine Scaffolds,” Chemistry Central Journal. 12 (2018): 1–29.
   PubMedGoogle Scholar
• S. B. Patwari, M. S. Murali, and V. B. Jadhav, “Microwave-Assisted Synthesis, Antimicrobial, and Cytotoxicity Activity of N-Tert-Butyl-3-{[2-(Arylamino)Pyrimidin-4-yl]Amino} Benzenesulfonamides,” Journal of Heterocyclic Chemistry 55, no. 12 (2018): 2911–2918. doi:10.1002/jhet.3364
   Web of Science ®Google Scholar
• K. K. Chikhalia, M. J. Patel, and D. B. Vashi, “Design, Synthesis and Evaluation of Novel Quinolinyl Chalcones as Antibacterial Agentsi,” Arkivoc 2008, no. 13 (2008): 189–197. doi:10.3998/ark.5550190.0009.d21
   Google Scholar
• H. Zhang, R. F. Schinazi, and C. K. Chu, “Synthesis of Neplanocin F Analogues as Potential Antiviral Agents,” Bioorganic & Medicinal Chemistry 14, no. 24 (2006): 8314–8322. doi:10.1016/j.bmc.2006.09.007
   PubMed Web of Science ®Google Scholar
• S. A. Rahaman, Y. R. Pasad, P. Kumar, and B. Kumar, “Synthesis and anti-Histaminic Activity of Some Novel Pyrimidines,” Saudi Pharmaceutical Journal: SPJ: The Official Publication of the Saudi Pharmaceutical Society 17, no. 3 (2009): 255–258. doi:10.1016/j.jsps.2009.08.001
   PubMedGoogle Scholar
• J. K. Gupta, P. K. Sharma, R. Dudhe, S. C. Mondal, A. Chaudhary, and P. K. Verma, “Synthesis and Analgesic Activity of Novel Pyrimidine Derivatives of Coumarin Moiety,” Acta Pol Pharm Drug Res 68 (2011): 785–793.
   PubMed Web of Science ®Google Scholar
• H. U. Rashid, M. A. U. Martines, A. P. Duarte, J. Jorge, S. Rasool, R. Muhammad, N. Ahmad, and M. N. Umar, “Research Developments in the Syntheses, anti-Inflammatory Activities and Structure–Activity Relationships of Pyrimidines,” RSC Advances 11, no. 11 (2021): 6060–6098. doi:10.1039/d0ra10657g
   PubMed Web of Science ®Google Scholar
• M. K. Sahoo, M. I. Lefterova, F. Yamamoto, J. J. Waggoner, S. Chou, S. P. Holmes, M. W. Anderson, and B. A. Pinsky, “Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation Sequencing,” Journal of Clinical Microbiology 51, no. 11 (2013): 3700–3710. doi:10.1128/JCM.01605-13
   PubMed Web of Science ®Google Scholar
• A. Faraji, T. O. Bakhshaiesh, Z. Hasanvand, R. Motahari, E. Nazeri, M. A. Boshagh, L. Firoozpour, H. Mehrabi, A. Khalaj, R. Esmaeili, et al. “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality as Potential Inhibitors of Angiogenesis,” European Journal of Medicinal Chemistry 214 (2021): 113228. doi:10.1016/j.ejmech.2021.113228
   PubMed Web of Science ®Google Scholar
• A. Katritzky, C. Ramsden, A. Eric, and R. Taylor, “Comprehensive Heterocyclic Chemistry, III,” in Pyrimidines and Their Benzo Derivatives, ed. G. W. Rewcastle (Antwerp, Belgium: Elsevier Ltd., 2008), 117–272.
   Google Scholar
• D. J. Brown, R. F. Evans, W. B. Cowden, and M. D. Fenn, Chemistry of Heterocyclic Compounds:The Pyrimidines (Canada: John Wiley & Sons, Inc., 1994).
   Google Scholar
• P. Biginelli, “Synthesis of 3,4-Dihydropyrimidin-2(1H)-Ones,” Gazzetta Chimica Italiana 23 (1893): 360.
   Google Scholar
• M. J. Frisch, G. W., Trucks H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, Gaussian 09, Revision D.01 (Wallingford, CT, USA: Gaussian, Inc., 2009).
   Google Scholar
• S. Huo, and S. Wang, “The Effectiveness of Phonological-Based Instruction in English as a Foreign Language Students at Primary School Level: A,” Research Synthesis Educational Psychology 2 (2017).
   Google Scholar
• I. V. Tetko, P. Bruneau, H. W. Mewes, D. C. Rohrer, and G. I. Poda, “Can we Estimate the Accuracy of ADME-Tox Predictions?,” Drug Discovery Today 11, no. 15–16 (2006): 700–707. doi:10.1016/j.drudis.2006.06.013
   PubMed Web of Science ®Google Scholar
• T. Hou, and J. Wang, “Structure-ADME Relationship: Still a Long Way to Go?”, Expert,” Expert Opinion on Drug Metabolism & Toxicology 4, no. 6 (2008): 759–770. doi:10.1517/17425255.4.6.759
   PubMed Web of Science ®Google Scholar
• L. Ferreira, R. dos Santos, G. Oliva, and A. Andricopulo, “Molecular Docking and Structure-Based Drug Design Strategies,” Computational Toxicology 20 (2015): 100157.
   Google Scholar
• S. Kalyaanamoorthy, and Y-PP. Chen, “Structure-Based Drug Design to Augment Hit Discovery,” Drug Discovery Today 16, no. 17–18 (2011): 831–839. doi:10.1016/j.drudis.2011.07.006
   PubMed Web of Science ®Google Scholar
• A. Amberg, “Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays,” in Silico Methods, ed. , H.G. Vogel (Berlin Heidelberg, Berlin, Heidelberg: Springer, 2013), 1273–1296.
   Google Scholar
• F. E. Agamah, G. K. Mazandu, R. Hassan, C. D. Bope, N. E. Thomford, A. Ghansah, and E. R. Chimusa, “Computational/in Silico Methods in Drug Target and Lead Prediction,” Briefings in Bioinformatics 21, no. 5 (2020): 1663–1675. doi:10.1093/bib/bbz103
   PubMed Web of Science ®Google Scholar
• I. Yusuf, U. Adamu, and U. Sani, “Computational Studies of a Series of 2-Substituted Phenyl-2-Oxo-, 2-Hydrox-yl- and 2-Acylloxyethylsulfonamides as Potent anti-Fungal Agents,” Heliyon 6 (2020): 1–6.
   Web of Science ®Google Scholar
• Thomas B. Knudsen, Douglas A. Keller, Miriam Sander, Edward W. Carney, Nancy G. Doerrer, David L. Eaton, Suzanne Compton Fitzpatrick, Kenneth L. Hastings, Donna L. Mendrick, Raymond R. Tice, et al. “FutureTox II: In Vitro Data and in Silico Models for Predictive Toxicology,” Toxicological Sciences : An Official Journal of the Society of Toxicology 143, no. 2 (2015): 256–267. doi:10.1093/toxsci/kfu234
   PubMed Web of Science ®Google Scholar
• E. Akbas, A. Ruzgar, B. C. Akbas, and E. Sahin, “Synthesis, Characterization and DFT Calculation of Some New Pyrimidine Derivatives and Theoretical Studies on the Corrosion Inhibition Performance,” Iranian Journal of Chemistry and Chemical Engineering 41 (2022): 5.
   Google Scholar
• T. Jin, S. Zhang, and T. Li, p-Toluenesulfonic Acid-Catalyzed Efficient Synthesis of Dihydropyrimidines: Improved High Yielding Protocol for the Biginelli Reaction, Marcel Dekker, Inc., (2011) 1847–1851.
   Google Scholar
• L. G. Itamar, et al. “Versatility of the Biginelli Reaction: Synthesis of New Biphenyl Dihydropyrimidin-2-Thiones Using Different Ketones as Building Blocks,” Tetrahedron Letters 59 (2018) : 2759–2762.
   Web of Science ®Google Scholar
• Adithya Adhikari, Balakrishna Kalluraya, K. V. Sujith, and Riaz Mahmood,   Gouthamchandra, “Synthesis, Characterization and Biological Evaluation of Dihydropyrimidine Derivatives,” Saudi Pharmaceutical Journal: The Official Publication of the Saudi Pharmaceutical Society 20, no. 1 (2012): 75–79. Volume doi:10.1016/j.jsps.2011.04.002
   PubMed Web of Science ®Google Scholar
• Gianluigi Lauro, Maria Strocchia, Stefania Terracciano, Ines Bruno, Katrin Fischer, Carlo Pergola, Oliver Werz, Raffaele Riccio, and Giuseppe Bifulco, “Exploration of the Dihydropyrimidine Scaffold for the Development of New Potential anti-Inflammatory Agents Blocking Prostaglandin E2 Synthase-1 Enzyme (mPGES-1),” European Journal of Medicinal Chemistry 80, no. 10 (2014): 407–415. doi:10.1016/j.ejmech.2014.04.061
   PubMedGoogle Scholar
• Y. Zhu, Y. Pan, and S. Huang, “Trimethylsilyl Chloride: A Facile and Efficient Reagent for One-Pot Synthesis of 3,4-Dihydropyrimidin-2(1H)-Ones,” Synthetic Communications 34, no. 17 (2004): 3167–3174. doi:10.1081/SCC-200028607
   Web of Science ®Google Scholar
• Z. Shen, X. Xu, and S. Ji, “Brønsted Base-Catalyzed One-Pot Three-Component Biginelli-Type Reaction: An Efficient Synthesis of 4,5,6-Triaryl-3,4-Dihydropyrimidin- 2(1H)-One and Mechanistic Study,” The Journal of Organic Chemistry 75, no. 4 (2010): 1162–1167. doi:10.1021/jo902394y
   PubMed Web of Science ®Google Scholar
• C. T. Lee, W. Yang, and R. G. Parr, “Development of the Colle-Salvetti Correlation-Energy Formula into a Functional of the Electron Density,” Physical Review. B, Condensed Matter 37, no. 2 (1988): 785–789. doi:10.1103/physrevb.37.785
   PubMed Web of Science ®Google Scholar
• Esvet Akbaş, Hamza Kahraman, and Begüm Çağla Akbaş, “Calculation of Usability as anti-Corrosion of Pyrimidine-Type Bases by Density Functional Theory,” International Journal of Chemistry and Technology 6, no. 1 (2022): 15–20. doi:10.32571/ijct.936862
   Google Scholar
• E. Akbas, E. Yildiz, and A. Erdogan, “Synthesis, Characterization and Theoretical Studies of Novel Pyrimidine Derivatives as Potential Corrosion Inhibitors,” Journal of the Serbian Chemical Society 85, no. 4 (2020) : 481–492. doi:10.2298/JSC190326081A
   Web of Science ®Google Scholar
• K. Rasheeda, V. D. P. Alva, P. A. Krishnaprasad, and S. Samshuddin, “Pyrimidine Derivatives as Potential Corrosion Inhibitors for Steel in Acid Medium—an Overview,” International Journal of Corrosion and Scale Inhibition 7 (2018): 48.
   Web of Science ®Google Scholar
• H. Turkez, M. I. Yousef, E. Sönmez, B. Togar, F. Bakan, P. Sozio, and A. D. Stefano, “Evaluation of Cytotoxic, Oxidative Stress and Genotoxic Responses of Hydroxyapatite Nanoparticles on Human Blood Cells,” Journal of Applied Toxicology 34, no. 4 (2014): 373–379. doi:10.1002/jat.2958
   PubMed Web of Science ®Google Scholar
• M. E. Arslan, H. Türkez, and A. Mardinoğlu, “In Vitro Neuroprotective Effects of Farnesene Sesquiterpene on Alzheimer’s Disease Model of Differentiated Neuroblastoma Cell Line,” The International Journal of Neuroscience 131, no. 8 (2021): 745–754. doi:10.1080/00207454.2020.1754211
   PubMed Web of Science ®Google Scholar
• B. Emsen, A. Aslan, B. Togar, and H. Turkez, “In Vitro Antitumor Activities of the Lichen Compounds Olivetoric, Physodic and Psoromic Acid in Rat Neuron and Glioblastoma Cells,” Pharmaceutical Biology 54, no. 9 (2016): 1748–1762. doi:10.3109/13880209.2015.1126620
   PubMed Web of Science ®Google Scholar
• Taner Arabaci, Hasan Türkez, Cenk Fatih Çanakçi, and Mehmet Özgöz, “Özgöz, Assessment of Cytogenetic and Cytotoxic Effects of Chlorhexidine Digluconate on Cultured Human Lymphocytes,” Acta Odontologica Scandinavica 71, no. 5 (2013): 1255–1260. doi:10.3109/00016357.2012.757646
   PubMed Web of Science ®Google Scholar
• M. Fenech, “The Cytokinesis Blocks Micronucleus Technique. A Detailed Description on the Method and Its Application to Genotoxicity Studies in Human Population,” Mutation Research 285, no. 1 (1993): 35–44. doi:10.1016/0027-5107(93)90049-l
   PubMed Web of Science ®Google Scholar
• H. Turkez, I. Cacciatore, M. E. Arslan, E. Fornasari, L. Marinelli, A. Di Stefano, and A. Mardinoglu, “Histidyl-Proline Diketopiperazine Isomers as Multipotent anti-Alzheimer Drug Candidates,” Biomolecules 10, no. 5 (2020): 737. doi:10.3390/biom10050737
   PubMed Web of Science ®Google Scholar
• A. Daina, O. Michielin, and V. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7, no. 1 (2017): 42717. doi:10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Advanced Drug Delivery Reviews 46, no. 1–3 (2001): 3–26. doi:10.1016/s0169-409x(00)00129-0
   PubMed Web of Science ®Google Scholar
• D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward, and K. D. Kopple, “Molecular Properties That Influence the Oral Bioavailability of Drug Candidates,” Journal of Medicinal Chemistry 45, no. 12 (2002): 2615–2623. doi:10.1021/jm020017n
   PubMed Web of Science ®Google Scholar
• W. J. Egan, K. M. Merz, and J. J. Baldwin, “Prediction of Drug Absorption Using Multivariate Statistics,” Journal of Medicinal Chemistry 43, no. 21 (2000): 3867–3877. doi:10.1021/jm000292e
   PubMed Web of Science ®Google Scholar
• A. K. Ghose, V. N. Viswanadhan, and J. J. Wendoloski, “A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases,” Journal of Combinatorial Chemistry 1, no. 1 (1999): 55–68. doi:10.1021/cc9800071
   PubMedGoogle Scholar
• I. Muegge, S. L. Heald, and D. Brittelli, “Simple Selection Criteria for Drug-like Chemical Matter,” Journal of Medicinal Chemistry 44, no. 12 (2001): 1841–1846. doi:10.1021/jm015507e
   PubMed Web of Science ®Google Scholar
• A. Daina and V. Zoete, “BOILED Egg to Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules,” Chemmedchem. 11, no. 11 (2016): 1117–1121. doi:10.1002/cmdc.201600182
   PubMed Web of Science ®Google Scholar
• P. Banerjee, A. O. Eckert, A. K. Schrey, and R. Preissner, “ProTox-II: A Webserver for the Prediction of Toxicity of Chemicals,” Nucleic Acid Res 46 (2018): 257–263.
   PubMed Web of Science ®Google Scholar
• L. Gossage, and T. Eisen, “Targeting Multiple Kinase Pathways: A Change in Paradigm,” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16, no. 7 (2010): 1973–1978. doi:10.1158/1078-0432.CCR-09-3182
   PubMed Web of Science ®Google Scholar
• D. S. Shewach, and R. D. Kuchta, “Introduction to Cancer Chemotherapeutics,” Chemical Reviews 109, no. 7 (2009): 2859–2861. doi:10.1021/cr900208x
   PubMed Web of Science ®Google Scholar
• A. M. S. El Newahie, Y. M. Nissan, N. S. M. Ismail, D. A. Abou El Ella, S. M. Khojah, and K. A. M. Abouzid, “Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers,” Molecules (Basel, Switzerland) 24, no. 6 (2019): 1175. doi:10.3390/molecules24061175
   PubMed Web of Science ®Google Scholar
• M. S. Abdelbaset, GEDA. Abuo-Rahma, M. H. Abdelrahman, M. Ramadan, B. G. M. Youssif, S. N. A. Bukhari, M. F. A. Mohamed, and M. Abdel-Aziz, “Novel Pyrrol-2(3H)-Ones and Pyridazin-3(2H)-Ones Carrying Quinoline Scaffold as anti-Proliferative Tubulin Polymerization Inhibitors,” Bioorganic Chemistry 80 (2018): 151–163. doi:10.1016/j.bioorg.2018.06.003
   PubMed Web of Science ®Google Scholar
• Q. Wu, Z. Yang, Y. Nie, Y. Shi, and D. Fan, “Multi-Drug Resistance in Cancer Chemotherapeutics: Mechanisms and Lab Approaches,” Cancer Letters 347, no. 2 (2014): 159–166. doi:10.1016/j.canlet.2014.03.013
   PubMed Web of Science ®Google Scholar
• M. F. A. Mohamed, M. Sh, A. Shaykoon, M. H. Abdelrahman, B. E. M. Elsadek, A. S. Aboraia, and GEDAA. Abuo-Rahma, “Design, Synthesis, Docking Studies and Biological Evaluation of Novel Chalcone Derivatives as Potential Histone Deacetylase Inhibitors,” Bioorganic Chemistry 72 (2017): 32–41. doi:10.1016/j.bioorg.2017.03.005
   PubMed Web of Science ®Google Scholar
• T. J. Ritchie, S. J. F. Macdonald, S. Peace, S. D. Pickett, and C. N. Luscombe, “Increasing Small Molecule Drug Developability in Suboptimal Chemical Space,” MedChemComm 4, no. 4 (2013): 673. doi:10.1039/c3md00003f
   Web of Science ®Google Scholar
• G. Ottaviani, D. J. Gosling, C. Patissier, S. Rodde, L. Zhou, and B. Faller, “What is Modulating Solubility in Simulated Intestinal Fluids?,” European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences 41, no. 3-4 (2010): 452–457. doi:10.1016/j.ejps.2010.07.012
   PubMed Web of Science ®Google Scholar
• K. T. Savjani, A. K. Gajjar, and J. K. Savjani, “Drug Solubility: Importance and Enhancement Techniques,” ISRN Pharmaceutics 2012 (2012): 195727. doi:10.5402/2012/195727
   PubMedGoogle Scholar
• J. S. Delaney, “ESOL: Estimating Aqueous Solubility Directly from Molecular Structure,” Journal of Chemical Information and Computer Sciences 44, no. 3 (2004): 1000–1005. doi:10.1021/ci034243x
   PubMedGoogle Scholar
• J. Ali, P. Camilleri, M. B. Brown, A. J. Hutt, and S. B. Kirton, “Revisiting the General Solubility Equation: In Silico Prediction of Aqueous Solubility Incorporating the Effect of Topographical Polar Surface Area,” Journal of Chemical Information and Modeling 52, no. 2 (2012): 420–428. doi:10.1021/ci200387c
   PubMed Web of Science ®Google Scholar
• R. O. Potts, and R. H. Guy, “Predicting Skin Permeability,” Pharmaceutical Research 9, no. 5 (1992): 663–669. doi:10.1023/a:1015810312465
   PubMed Web of Science ®Google Scholar
• V. N. Toan, N. D. Thanh, and N. M. Tri, “1,3,4-Thiadiazoline Coumarin Hybrid Compounds Containing D-Glucose/D-Galactose Moieties: Synthesis and Evaluation of Their Antiproliferative Activity,” Arab J. Chem 4 (2021): 103053.
   Google Scholar
• E. Spaczyńska, A. Mrozek-Wilczkiewicz, K. Malarz, J. Kos, T. Gonec, M. Oravec, R. Gawecki, A. Bak, J. Dohanosova, I. Kapustikova, et al. “Design and Synthesis of Anticancer 1-Hydroxynaphthalene-2-Carboxanilides with a p53 Independent Mechanism of Action,” Scientific Reports 9, no. 1 (2019): 6387. doi:10.1038/s41598-019-42595-y
   PubMedGoogle Scholar
• S. Li, H. He, L. J. Parthiban, H. Yin, and A. T. M. Serajuddin, “IV-IVC Considerations in the Development of Immediate-Release Oral Dosage Form,” Journal of Pharmaceutical Sciences 94, no. 7 (2005): 1396–1417. doi:10.1002/jps.20378
   PubMed Web of Science ®Google Scholar
• J. Kelder, P. D. Grootenhuis, D. M. Bayada, L. P. Delbressine, and J. P. Ploemen, “Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs,” Pharmaceutical Research 16, no. 10 (1999): 1514–1519. doi:10.1023/a:1015040217741
   PubMed Web of Science ®Google Scholar
• K. Palm, K. Luthman, A. L. Unge, G. Strandlund, and P. Artursson, “Correlation of Drug Absorption with Molecular Surface Properties,” Journal of Pharmaceutical Sciences 85, no. 1 (1996): 32–39. doi:10.1021/js950285r
   PubMed Web of Science ®Google Scholar
• P. K. Pandey, A. K. Sharma, and U. Gupta, “Blood Brain Barrier: An Overview on Strategies in Drug Delivery, Realistic in Vitro Modeling and in Vivo Live Tracking,” Tissue Barriers 4 (2016): 1129476.
   PubMed Web of Science ®Google Scholar
• U. M. Zanger, and M. Schwab, “Cytochrome P450 Enzymes in Drug Metabolism: Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation,” Pharmacology & Therapeutics 138, no. 1 (2013): 103–141. doi:10.1016/j.pharmthera.2012.12.007
   PubMed Web of Science ®Google Scholar
• Y. Masubuchi, and T. Horie, “Toxicological Significance of Mechanism-Based Inactivation of Cytochrome p450 Enzymes by Drugs,” Critical Reviews in Toxicology 37, no. 5 (2007): 389–412. doi:10.1080/10408440701215233
   PubMed Web of Science ®Google Scholar
• T. Lj. Sestic, J. J. Ajdukovic, M. A. Marinovic, E. T. Petri, and M. P. Savi, “In Silico ADMET Analysis of the a-, B- and D-Modified Androstane Derivatives with Potential Anticancer Effects,” Steroids 189 (2023): 109147. doi:10.1016/j.steroids.2022.109147
   PubMed Web of Science ®Google Scholar
• J. Baell, and M. A. Walters, “Chemistry: Chemical Con Artists Foil Drug Discovery,” Nature 513, no. 7519 (2014): 481–483. doi:10.1038/513481a
   PubMed Web of Science ®Google Scholar
• J. B. Baell, and G. A. Holloway, “New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays,” Journal of Medicinal Chemistry 53, no. 7 (2010): 2719–2740. doi:10.1021/jm901137j
   PubMed Web of Science ®Google Scholar
• S. D. Nelson, “Metabolic Activation and Drug Toxicity,” Journal of Medicinal Chemistry 25, no. 7 (1982): 753–765. doi:10.1021/jm00349a001
   PubMed Web of Science ®Google Scholar
• A. S. Kalgutkar, I. Gardner, R. S. Obach, C. L. Shaffer, E. Callegari, K. R. Henne, A. E. Mutlib, D. K. Dalvie, J. S. Lee, Y. Nakai, et al. “A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups,” Current Drug Metabolism 6, no. 3 (2005): 161–225. doi:10.2174/1389200054021799
   PubMed Web of Science ®Google Scholar
• S. J. Teague, A. M. Davis, P. D. Leeson, and T. Oprea, “The Design of Leadlike Combinatorial Libraries,” Angewandte Chemie International Edition 38, no. 24 (1999): 3743–3748. doi:10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U
   PubMed Web of Science ®Google Scholar